We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current INFI market cap is 2.88M. The company's latest EPS is USD -0.4962 and P/E is -0.02.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 686k | 712k | 543k | 731k | 583k |
| Operating Income | -12.02M | -10.88M | -9.54M | -11.51M | -10.12M |
| Net Income | -11.99M | -10.72M | -9.23M | -11.05M | -9.96M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.15M | 3.05M | 1.72M | 1.86M | 2.59M |
| Operating Income | -11.93M | -45.66M | -38.5M | -45.08M | -44.84M |
| Net Income | -11.25M | -47.06M | -40.49M | -45.26M | -44.37M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 61.86M | 51.59M | 42.15M | 29.95M | 21.23M |
| Total Liabilities | 62.96M | 62.47M | 61.2M | 58.27M | 58.64M |
| Total Equity | -1.11M | -10.87M | -19.05M | -28.32M | -37.41M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 60.22M | 49.01M | 39.32M | 84.79M | 42.15M |
| Total Liabilities | 7.76M | 41.29M | 62.31M | 63.21M | 61.2M |
| Total Equity | 52.46M | 7.73M | -22.99M | 21.57M | -19.05M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -24.13M | -33.53M | -42.43M | -12.58M | -20.58M |
| Investing | -10.79M | -55k | -55k | N/A | N/A |
| Financing | 28k | 42k | 73k | N/A | 16k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.71M | -41.53M | -35.74M | -40.62M | -42.43M |
| Investing | 13.1M | -12.24M | 14.63M | 5.49M | -55k |
| Financing | 5.62M | 27.73M | 27.44M | 87.11M | 73k |
| Market Cap | 2.88M |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0.34 |
| Price to Cash Ratio | 0.02 |
| Price to Book Ratio | -0.05 |
| Dividend Yield | - |
| Shares Outstanding | 89.41M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -80.38% |
| 52 Week High | 0.2597 |
| 52 Week Low | 0.0233 |
| Spread (Intraday) | 0 (7.76%) |
| Company Name | Infinity Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.infi.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
